Haemonetics
Haemonetics is a global healthcare company dedicated to providing innovative medical products and solutions to improve patient care and reduce healthcare costs. They operate in important medical markets including blood and plasma component collection, surgical suite, and hospital transfusion services. The company emphasizes quality, integrity, and making a meaningful impact on patients worldwide.
Industries
Nr. of Employees
Very Large (1000+)
Haemonetics
Boston, Massachusetts, United States
Patents
Products
Apheresis and plasma collection systems
Automated medical devices and associated consumables designed to collect plasma and other blood components in donor centers and blood banks.
Intraoperative blood recovery (cell salvage) systems
Devices and consumables used in the surgical suite to recover, process and return a patient’s blood during surgery.
Viscoelastic hemostasis analyzers
Diagnostic analyzers and cartridges for viscoelastic assessment of coagulation used in perioperative and critical care settings.
Transfusion and blood management software
Software products to manage transfusion workflows, blood product tracking and hospital blood bank operations.
Interventional device technologies (pressure-sensing guidewires and esophageal cooling devices)
Commercialized specialty interventional technologies including fiber-optic pressure-sensing guidewire technologies and esophageal cooling devices for peri-procedural applications.
Apheresis and plasma collection systems
Automated medical devices and associated consumables designed to collect plasma and other blood components in donor centers and blood banks.
Intraoperative blood recovery (cell salvage) systems
Devices and consumables used in the surgical suite to recover, process and return a patient’s blood during surgery.
Viscoelastic hemostasis analyzers
Diagnostic analyzers and cartridges for viscoelastic assessment of coagulation used in perioperative and critical care settings.
Transfusion and blood management software
Software products to manage transfusion workflows, blood product tracking and hospital blood bank operations.
Interventional device technologies (pressure-sensing guidewires and esophageal cooling devices)
Commercialized specialty interventional technologies including fiber-optic pressure-sensing guidewire technologies and esophageal cooling devices for peri-procedural applications.
Services
Provision of training resources and learning programs for hospital, blood center and plasma center personnel and distributor partners; includes online mandatory compliance training.
Customer-facing technical support, product documentation distribution (instructions for use, safety data sheets, product certificates) and order/after-sales support.
Manufacturing of consumables and coordination of contract manufacturing for devices, plus global distribution and inventory management from multiple regional centers.
Provision of training resources and learning programs for hospital, blood center and plasma center personnel and distributor partners; includes online mandatory compliance training.
Customer-facing technical support, product documentation distribution (instructions for use, safety data sheets, product certificates) and order/after-sales support.
Manufacturing of consumables and coordination of contract manufacturing for devices, plus global distribution and inventory management from multiple regional centers.
Expertise Areas
- Blood and plasma collection systems development
- Transfusion and blood management software
- Hemostasis diagnostics (viscoelastic testing)
- Medical device manufacturing and consumables production
Key Technologies
- Apheresis and plasma-collection systems
- Viscoelastic hemostasis analyzers
- Transfusion and blood management software
- Device control and embedded software for collection systems
News & Updates
Announcement of presentation at the conference on May 30, 2025.
Earnings release available on investor relations website on May 8, 2025.
Results to be published on May 8, 2025.
Leadership updates announced on March 3, 2025.
ISO:14001-2015 Certification for Manufacturing Plants
Certification for environmental management systems at plants in Penang, Malaysia, and Pittsburgh, PA.
MDR CE Mark for VASCADE® Portfolio
Certification for the VASCADE® portfolio in Europe.
Announcement of presentation at the conference on May 30, 2025.
Earnings release available on investor relations website on May 8, 2025.
Results to be published on May 8, 2025.
Leadership updates announced on March 3, 2025.
ISO:14001-2015 Certification for Manufacturing Plants
Certification for environmental management systems at plants in Penang, Malaysia, and Pittsburgh, PA.
MDR CE Mark for VASCADE® Portfolio
Certification for the VASCADE® portfolio in Europe.